SAXO2
Stabilizer of axonemal microtubules 2
Also known as: DKFZp666G057, FAM154B, SAXO2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q658L1
- Gene
- SAXO2
- Ensembl
- ENSG00000188659
- Chromosome
- 15
- Canonical length
- 398 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Centrosome,Cytosol,Connecting piece,Mid piece
OverviewNCBI Gene
Predicted to enable microtubule binding activity. Predicted to be active in microtubule cytoskeleton; nucleus; and sperm flagellum. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
398 residues, UniProt reviewed canonical sequence.
>Q658L1|SAXO2
1 MGAKSMRSWC LCQICSCGSD YCPYEIVKQP RHVPEEYKPK QGKIDLGTTY KRDLNSYKVQ
61 PVAIVRPLER QVKKGKLDTV PTYKDDYRAW DLHKSELYKP EQTYHPPTVK FGNSTTFQDD
121 FVPQEIKPRQ SFKPSSVVKR STAPFNGITS HRLDYIPHQL ELKFERPKEV YKPTDQRFED
181 LTTHRCDFQG LIGETAKLCR PVHTRVTQNA LFEGSTEFRE SFQPWEIPPP EVKKVPEYVP
241 PTGSMLLNST SHLDYVPYQA NHVVPIRPVS QKRSNNFPFQ GKSIMKEDFP AWESCRQGLI
301 KKQQQIPNPS GKFDGLSTFR SHYVPHELIP TESCKPLNIA FKSSVPFDDV TMYSVEYTPK
361 RQEICPASYP SPPGYIFDNT NSQGHKFFRK IIPAVKAFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SAXO2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 48 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 48 nTPM
- testis: 19 nTPM
- epididymis: 17 nTPM
- choroid plexus: 6.7 nTPM
- lung: 6.1 nTPM
- retina: 5.7 nTPM
Single-cell type
- respiratory ciliated cells: 639 nCPM
- fallopian tube ciliated cells: 293 nCPM
- late spermatids: 259 nCPM
- late primary spermatocytes: 121 nCPM
- ependymal cells: 121 nCPM
- endometrial ciliated cells: 117 nCPM
Immune cell
- naive B-cell: 3.2 nTPM
- eosinophil: 2.9 nTPM
- NK-cell: 1.9 nTPM
- memory CD8 T-cell: 1.5 nTPM
- memory B-cell: 1.2 nTPM
- naive CD4 T-cell: 0.9 nTPM
Brain region
- choroid plexus: 20 nTPM
- midbrain: 14 nTPM
- white matter: 12 nTPM
- spinal cord: 9.9 nTPM
- medulla oblongata: 9.7 nTPM
- cerebral cortex: 9.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.81
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SAXO2 as an antibody target. Whether an autoantibody or antibody against SAXO2 could matter depends on whether native SAXO2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SAXO2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SAXO2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...